Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’

Detalles Bibliográficos
Autores principales: Zgaga, L, Vaughan-Shaw, P G, O’Sullivan, F, Farrington, S M, Theodoratou, E, Campbell, H, Dunlop, M G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520522/
https://www.ncbi.nlm.nih.gov/pubmed/28641317
http://dx.doi.org/10.1038/bjc.2017.185
_version_ 1783251829620998144
author Zgaga, L
Vaughan-Shaw, P G
O’Sullivan, F
Farrington, S M
Theodoratou, E
Campbell, H
Dunlop, M G
author_facet Zgaga, L
Vaughan-Shaw, P G
O’Sullivan, F
Farrington, S M
Theodoratou, E
Campbell, H
Dunlop, M G
author_sort Zgaga, L
collection PubMed
description
format Online
Article
Text
id pubmed-5520522
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55205222018-07-11 Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’ Zgaga, L Vaughan-Shaw, P G O’Sullivan, F Farrington, S M Theodoratou, E Campbell, H Dunlop, M G Br J Cancer Letters to the Editor Nature Publishing Group 2017-07-11 2017-06-22 /pmc/articles/PMC5520522/ /pubmed/28641317 http://dx.doi.org/10.1038/bjc.2017.185 Text en Copyright © 2017 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letters to the Editor
Zgaga, L
Vaughan-Shaw, P G
O’Sullivan, F
Farrington, S M
Theodoratou, E
Campbell, H
Dunlop, M G
Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title_full Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title_fullStr Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title_full_unstemmed Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title_short Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’
title_sort reply to ‘comment on ‘the impact of vitamin d pathway genetic variation and circulating 25-hydroxyvitamin d on cancer outcome: systematic review and meta-analysis’’
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520522/
https://www.ncbi.nlm.nih.gov/pubmed/28641317
http://dx.doi.org/10.1038/bjc.2017.185
work_keys_str_mv AT zgagal replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT vaughanshawpg replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT osullivanf replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT farringtonsm replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT theodoratoue replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT campbellh replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis
AT dunlopmg replytocommentontheimpactofvitamindpathwaygeneticvariationandcirculating25hydroxyvitamindoncanceroutcomesystematicreviewandmetaanalysis

Ejemplares similares